ABSTRACT & COMMENTARY

Anticholinergic Use for Three Months or More Increases Dementia Risk

June 1, 2021

There is a significant increase in dementia risk associated with the use of anticholinergic medications for three months or longer.

Issue Date: June 1, 2021

Table of Contents

Financial Disclosure: Dr. Rebecca H. Allen (editor) reports that she receives grant/research support from Bayer, and is a consultant for Bayer, Mylan, and Merck. Dr. Sarah J. Betstadt (peer reviewer) reports that she is on the speakers bureau for Merck. All of the relevant financial relationships listed for these individuals have been mitigated. None of the remaining planners or authors for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Subscription Publication Books & Study Guides Group & Site Licenses State CME/CE Requirements